• Blog
  • Onco Nutrition & Supplements Market Size & Share Analysis | 2023-2028

    Onco Nutrition & Supplements Market Size & Share Analysis | 2023-2028

    Onco Nutrition & Supplements Market Size & Share Analysis | 2023-2028
    Report code - SRHL131 Delivery - 2 Weeks
    Onco Nutrition & Supplements Market Size, Share, Trend, Forecast, & Growth Analysi See more...

    Market Insights

    Onco Nutrition & Supplements Market is likely to witness an impressive CAGR of 8.0% during the forecast period. Major factors such as increasing demand for cancer treatments and rising nutritional demand among cancer patients are driving market growth. Furthermore, technological advancements and growing awareness among oncology patients about the importance of essential nutrients are expected to drive the growth of the market during the forecast period.

    Onco-Nutrition-&-Supplements-Market-Insights

    Wish to get a free sample? Click Here

    What is Onco Nutrition & Supplements?

    Onco Nutrition & Supplements is a dietary and nutritional management for cancer patients that aims to improve bodily resources, increase tolerance for cancer treatments, and improve cancer patients' quality of life.

    Onco Nutrition & Supplements Market Highlights

    Market Growth (2023-2028)

    8% CAGR

    Base Year of Study

    2022

    Trend Period

    2017-2021

    Forecast Period

    2023-2028

    Segments Covered

    By Cancer Type (Blood Cancer, Liver Cancer, Pancreatic Cancer, Breast Cancer, Colorectal Cancer, Head & Neck Cancer, Lung Cancer, Stomach Cancer, Gastrointestinal Cancer, and Others),

    By Distribution Channel Type (Hospital Stores, Retail Pharmacy, and Online Pharmacy),

    By End-User Type (Hospital, Cancer Care Centers, Specialty Clinics, Homecare Centers, and Others),

    By Region (North America, Europe, Asia-Pacific, and Rest of the World).

    Segments Analysis

    By Cancer Type

    Based on the cancer type, the market is segmented as blood cancer, liver cancer, pancreatic cancer, breast cancer, colorectal cancer, head & neck cancer, lung cancer, stomach cancer, gastrointestinal cancer, and others. The head and neck cancer segment is expected to hold the major share of the market during the forecast period, owing to the increase in the number of cases worldwide and growing awareness among patients about the benefits of onco nutrition and supplements.

    By End-User Type

    Based on the end-user type, the market is segmented as hospital, cancer care centers, specialty clinics, homecare centers, and others. The hospital segment is estimated to account for the major share of the market during the forecast period. The segment's growth is owing to the wide range of services provided by hospitals, such as medical nutrition therapy, nutrition screening & assessment, food safety counseling for chemo patients, and preoperative and postoperative patient counseling. Furthermore, many healthcare facilities are specialized in providing nutrition support to radiation patients, nutrition counseling for cancer survivors, therapeutic diet planning, and teaching classes and academic workshops on nutrition-related topics.

    Regional Insights

    In terms of regions, North America is estimated to be the leading region in the market during the forecast period. The growth of the region’s market is owing to the increasing prevalence of chronic diseases and a rapidly aging population. Furthermore, the availability of advanced healthcare facilities and the launch of new nutrition products are expected to drive market growth during the forecast period. Europe and Asia-Pacific are also expected to offer substantial growth opportunities over the forecast period.

    Onco-Nutrition-&-Supplements-Market-Regional-Insights

    Know which region offers the best growth opportunities. Register Here

    Market Segmentation

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    The market is segmented into the following categories.

    By Cancer Type

    • Blood Cancer
    • Liver Cancer
    • Pancreatic Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Head & Neck Cancer
    • Lung Cancer
    • Stomach Cancer
    • Gastrointestinal Cancer
    • Others

    By Distribution Channel Type

    • Hospital Stores
    • Retail Pharmacy
    • Online Pharmacy

    By End-User Type

    • Hospitals
    • Cancer Care Centers
    • Specialty Clinics
    • Homecare Centers
    • Others

    By Region

    • North America (Country Analysis: the USA, Canada, and Mexico)
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and the Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and the Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Onco-Nutrition-&-Supplements-Market-Segmentation

    Want to know the most attractive market segments? Click Here

    Key Players

    Some of the key players in the onco nutrition & supplements market are-

    • Abbott Laboratories,
    • Allergan,
    • B. Braun Melsungen AG,
    • Baxter International, Inc.,
    • Danone S.A.,
    • Fresenius SE & Co. KGaA,
    • Grifols, S.A.,
    • Nestlé S.A.,
    • Pfizer, Inc.,
    • Sichuan Kelun Pharmaceutical Co., Ltd.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Market Trend and Forecast Analysis
    • Market segment trend and forecast
    • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
    • Attractive market segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors

    Report Features

    Market Segmentation

    4

    Regions Covered

    4

    Countries/Sub-Regions Covered

    17

    No. of Figures & Tables

    >150

    Company Profiles

    10

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation by any one of the cancer types by end-user type.

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    The onco nutrition & supplements market is expected to witness an impressive growth of 8% CAGR from 2023 to 2028.

    Onco nutrition & supplements is a dietary and nutritional management for cancer patients that aims to improve bodily resources, increase tolerance for cancer treatments, and improve cancer patients' quality of life.

    Some of the key players in the market are Abbott Laboratories, Allergan, B. Braun Melsungen AG, Baxter International, Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols, S.A., Nestl S.A., Pfizer, Inc., and Sichuan Kelun Pharmaceutical Co., Ltd.

    North America is estimated to be the leading region in the market during the forecast period.

    The head and neck cancer segment is expected to hold the major share of the market during the forecast period,

    The hospital segment is estimated to account for the major share of the market during the forecast period